Another Billion-Dollar Exit: Japanese Pharma Firm Buys Israeli Parkinson Therapy Developer

Mitsubishi Tanabe Pharma Corporation headquarters, in Doshomachi, Chuo-ku, Osaka-City, Osaka, Japan … Until the sale, the stock had appreciated 230 percent from its IPO. The deal has received unanimous approval by NeuroDerm’s Board of Directors …
( read original story …)